Assessment and training technologies in rehabilitation and sports biomechanics producing innovative measuring and medical device
Kinvent has raised $17.4M in total funding. The most recent round was Series B. The last funding was announced in January 2024.
Kinvent's investors include Bpifrance, Eurazeo, IncubAlliance Paris-Saclay, Uni.Fund, Sofilaro.
Kinvent is headquartered in Montpellier, France.
Assessment and training technologies in rehabilitation and sports biomechanics producing innovative measuring and medical device
Kinvent is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kinvent — Funding & Investors." VCBacked, January 18, 2024, https://www.vcbacked.co/company/kinvent. Accessed July 19, 2026.
VCBacked. (2024). Kinvent — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/kinvent
{{cite web |title=Kinvent — Funding & Investors |url=https://www.vcbacked.co/company/kinvent |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated